Assessing Arthritis in People With Diabetes | Opinion Article

Arthritis is the most common cause of disability in the United States and is a barrier to physical activity. Recent research has suggested that arthritis may also increase

FDA Approves Xgeva for Giant Cell Tumor of the Bone | Opinion Article

The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone

Diabetes: A Predictor of Severe Osteoarthritis? | News Brief

Type 2 diabetes appears to predict the development of severe osteoarthritis, independent of age, BMI, and other risk factors, according to European investigators. The study group noted

AAOS 2013: Assessing the Long-Term Benefits of THA | News Brief

The Particulars: Data are lacking on the long-term benefits and risks of total hip arthroplasty (THA) on overall health and healthcare spending in osteoarthritic patients. Data Breakdown:

AAOS 2013: Sexual Function Improves With THA & TKA | News Brief

The Particulars: Previous investigations have suggested that osteoarthritis of the hip and knee affect sexual activity. The ability of total hip arthroplasty (THA) and total knee arthroplasty

Educating Arthritic Patients on CVD Risks | News Brief

British research indicates that patient education appears to play a significant role in cardiovascular disease (CVD) risk factor modification in patients with rheumatoid arthritis. An 8-week cognitive

A Look at Complications After Total Joint Arthroplasty | News Brief

Results of a meta-analysis suggest that patients with rheumatoid arthritis (RA) appear to be at higher risk for dislocation following total hip arthroplasty than those with osteoarthritis

Total Knee Arthroplasty Among Medicare Beneficiaries | Feature

While hospital length of stay for total knee arthroplasty is decreasing, hospital readmission rates and infectious complication rates appear to be increasing.

Updated Guidelines for RA Treatment | Opinion Article

The ACR update re-emphasizes the importance of aggressive treatment in early RA. In addition to better outcomes, early intensive treatment can help patients maintain physical function and quality of life.

Simple Tasks Campaign: The Value of Rheumatology | Medical Blog

The American College of Rheumatology’s Simple Tasks campaign is designed to educate lawmakers, administration officials, think tanks, advocacy groups, physicians and physician groups about the value of

Newsworthy Research from 2012 ACR/ARHP | Conference Coverage

More than 20 rheumatology studies were selected as newsworthy and highlighted during the 2012 ACR/ARHP Annual Meeting. 

Examining Chronic Opioid Use in TKA | Feature

Physicians should take time to educate patients about the risks associated with chronic opioid use. Surgical results may not be optimal if patients chronically use these powerful medications before TKA.

Stroke Risk in Hip Replacement Patients | News Brief

Patients undergoing total hip replacement (THR) have 4.7-fold and 4.4-fold increased risks of ischemic stroke and hemorrhagic stroke, respectively, during their first 2 postoperative weeks, according to

Updating Osteoarthritis Treatment Recommendations | Opinion Article

New therapies for osteoarthritis and additional information on the safety and acceptability of existing therapies for patients with the condition have emerged.

FDA Approves Xeljanz for Rheumatoid Arthritis | Opinion Article

The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response

FDA Approves Expanded Indication for Actemra in Rheumatoid Arthritis | Opinion Article

Genentech, Inc., a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for Actemra (tocilizumab) for

FDA Clears EchoSoft Diagnostic Ultrasound Technology | Opinion Article

Echometrix LLC today announced that it has received clearance from the U.S. Food and Drug Administration to market its EchoSoftTM ultrasound technology. EchoSoft is Echometrix’ first commercial

Conference Highlights: ASE 2012 | Conference Coverage

New research was presented at ASE 2012, the American Society of Echocardiography’s 23rd Annual Scientific Sessions, from June 30 to July 3 in Maryland. The features below

New Guidelines on Osteoporosis in Men | Medical Blog

This week, the Endocrine Society issued guidelines on managing osteoporosis in men. Published in the June 1, 2012 issue of Journal of Clinical Endocrinology & Metabolism, the

The Effects of Weight on Disc Degeneration | News Brief

Chinese research indicates that there appears to be a significant association between the presence, extent, and global severity of disc degeneration and BMI. In adults with disc

Page 5 of 6« First...23456